Breaking the Mortality Curve: Investment-Driven Acceleration in Life Expectancy and Insurance Innovation
Capital investment in longevity science—research targeting the biological processes of aging through interventions like cellular reprogramming, AI-driven drug discovery, and biological age monitoring—may create significant divergence between traditional actuarial projections and emerging mortality i...
Saved in:
Main Author: | David M. Dror |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Risks |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9091/13/7/122 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PROCESS-FUNCTIONAL MECHANISM FOR INSURING INVESTMENT RISKS OF BUSINESS ENTITIES
by: Святослав Покорчак, et al.
Published: (2025-06-01) -
Investigating potential links between gut microbiome, clinical parameters, and mortality in long-living male patients receiving multi-drug therapy
by: Quanxin Wu, et al.
Published: (2025-07-01) -
Insurance in the Eurasian Economic Union (EAEU)
by: U. T. Kadyrkulov, et al.
Published: (2021-04-01) -
Expert Study of the Execution of the Terms of an Investment Life Insurance Contract
by: O. A. Abelev, et al.
Published: (2021-04-01) -
Ways to Increase the Efficiency of Investment Activities of Insurance Companies in Uzbekistan
by: N. M. Babaeva
Published: (2024-04-01)